University of Pennsylvania Health System CERL080AUS90 — Philadelphia, Pennsylvania

University of Pennsylvania Health System CERL080AUS90 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pennsylvania Health System CERL080AUS90 has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania Health System CERL080AUS90?

University of Pennsylvania Health System CERL080AUS90 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania Health System CERL080AUS90 conducted?

University of Pennsylvania Health System CERL080AUS90 has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Is University of Pennsylvania Health System CERL080AUS90 accredited by Crixeo Health?

University of Pennsylvania Health System CERL080AUS90 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania Health System CERL080AUS90?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.